Gabapentin inhibits calcium currents in isolated rat brain neurons

Neuropharmacology

Volumn 37, Issue 1, 1998, Pages 83-91

  Stefani, Alessandro ^a,b   Spadoni, Francesca ^a,b   Bernardi, Giorgio ^a,b  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Anticonvulsants; Calcium currents; Dihydropyridines; Gabapentin; Neuroprotective agents

Indexed keywords

ANTICONVULSIVE AGENT; CALCIUM CHANNEL; CALCIUM ION; DIHYDROPYRIDINE DERIVATIVE; GABAPENTIN; NIFEDIPINE; NIMODIPINE; OMEGA CONOTOXIN GVIA; OMEGA CONOTOXIN MVIIC; PROTEIN SUBUNIT;

ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CALCIUM CURRENT; CONTROLLED STUDY; CONVULSION; DRUG MECHANISM; GLOBUS PALLIDUS; NEOCORTEX; NERVE CELL EXCITABILITY; NERVE CELL LESION; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETIC ACIDS; AMINES; ANIMALS; ANTICONVULSANTS; BRAIN; CALCIUM CHANNEL BLOCKERS; CYCLOHEXANECARBOXYLIC ACIDS; GAMMA-AMINOBUTYRIC ACID; GLOBUS PALLIDUS; MALE; NEOCORTEX; NEOSTRIATUM; NEURONS; PATCH-CLAMP TECHNIQUES; RATS; RATS, WISTAR;

EID: 0031809165     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(97)00189-5     Document Type: Article

References (51)

1. Beydoun A., Uthman B.M., Sackellares J.C. Gabapentin: pharmacokinetics, efficacy and safety. Clin. Neuropharmacol. 18:1995;469-481.
2. Brust P.F., Simerson S., McCue A.F. et al. Human neuronal voltage-dependent calcium channels: studies on subunit structure and role in channel assembly. Neuropharmacology. 32:1993;1089-1102.
3. Buetefisch C.M., Gutierrez A., Gutman L. Choreoathetotic movements: a possible side effect of gabapentin. Neurology. 46:1996;851-852.
4. Calabresi P., Stefani A., DeMurtas M., Pisani A., Sancesario G., Bernardi G. Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission. Epilepsia. 336:1995;990-996.
5. Calabresi A., Siniscalchi A., Pisani A., Stefani A., Mercuri N.B., Bernardi G. A field potential analysis on the effects of lamotrigine, GP 47779 and felbamate in neocortical slices. Neurology. 47:1996;557-562.
6. Catterall W.A. Structure and function of voltage-gated ion channels. Annu. Rev. Biochem. 64:1995;493-531.
7. 2+ channels involves multiple receptor subtypes in cortical neurons. J. Neurosci. 16:1996;38-45.
8. Cochran J.W. Restless legs syndrome. J. Am. Med. Assoc. 275:1996;187.
9. Dolphin A.D. Facilitation of currents in excitable cells. Trends Neurosci. 19:1996;35-43.
10. Ellis S.B., Williams M.E., Ways N.R. et al. Sequence and expression of mRNAs encoding the alfa 1 and alfa 2 subunit of a DHP-sensitive calcium channel. Science. 241:1988;1661-1664.
11. Gee N.S., Brown J.P., Dissanayake V.U.K., Offord J., Thurlow R., Woodruff G.N. The novel anticonvulsant drug, Gabapentin (Neurontin), binds to the α2δ subunit of a calcium channel. J. Biol. Chem. 271:1996;5768-5776.
12. Goldlust A., Su T.Z., Welty D.F., Taylor C.P., Oxender D.L. Effects of anticonvulsant drug gabapentin on the enzymes in metabolic pathways of glutamate and GABA. Epilepsy Res. 22:1995;1-11.
13. 2+ channel α2δ subunit in current stimulation and subunit interaction. Neuron. 16:1996;431-440.
14. Gurney M.E., Cuttings F.B., Zhai P., Doble A., Taylor C.P., Andrus P.K., Hall E.D. Benefit of vitamin E, Riluzole and Gabapentin in a transgenic model of familail amyotrophic lateral sclerosis. Ann. Neurol. 39:1996;147-157.
15. Honmou O., Kocsis J.D., Richerson G.B. Gabapentin potentiates the conductance incraese induced by nipecotic acid in CA1 pyramidal neurns in vitro. Epilepsy Res. 20:1995;193-202.
16. Isom L.L., De Jongh K.S., Catterall W.A. Auxiliary subunits of voltage-gated ion channels. Neuron. 12:1994;1183-1194.
17. Kanthasamy A.G., Vu T.Q., Yun R.J., Truong D.D. Antimyoclonic effect of gabapentin in a posthypoxic model of myoclonus. Eur. J. Pharmacol. 297:1996;219-224.
18. Kocsis J.D., Honmou O. Gabapentin increases GABA-induced depolarization in rat neonatal optic nerve. Neurosci. Lett. 169:1994;181-184.
19. Larkin J.G., Besag F.M.C., Cox A., Brodie M.J. Nifedipine for epilepsy? A double-blind, placebo-controlled study. Epilepsia. 33:1992;346-352.
20. Leiderman D.B. Gabapentin as add-on therapy for refractory partial epilepsy: results of five placebo-controlled trials. Epilepsia. 35:1994;S74-S76.
21. Lorenzon N.M., Foehring R.C. Characterization of pharmacologically identified voltage-gated calcium channels in acutely isolated rat neocortical neurons. I Adult neurons. J. Neurophysiol. 73:1995;1430-1442.
22. Macdonald R.L., Kelly M.K. Mechanisms of action of currently prescribed and newly developed antiepileptic drugs. Epilepsia. 35:1994;S41-S50.
23. Macdonald R.L., Greenfield J.L. Jr. Mechanisms of action of new antiepileptic drugs. Curr. Opin. Neurol. 10:1997;121-128.
24. McLean M.J., Macdonald R.L. Multiple actions of phenytoin on mouse spinal cord neurons in cell culture. J. Pharm. Exp. Ther. 227:1983;779-789.
25. Meldrum B.S. Update on the mechanism of action of antiepileptic drugs. Epilepsia. 37:1996;S4-S11.
26. Mellick G.A., Mellick LB. Management of restless legs syndrome with gabapentin (Neurontin). Sleep. 19:1996;224-226.
27. Mikami A., Imoto K., Tanabe T. et al. Primary structure and functional expression of the cardiac dihydropyridine-sensitive calcium channel. Nature. 340:1989;230-233.
28. Patel J., Naritoku D.K. Gabapentin for the treatment of hemifacial spasms. Clin. Neuropharmacol. 19:1996;185-188.
29. Petroff O.A., Rothman D.L., Behar K.L., Lamoureux D., Mattson R.H. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy. Ann. Neurol. 39:1996;95-99.
30. Pisani A., Stefani A., Siniscalchi A., Mercuri N.B., Bernardi G., Calabresi P. Electrophysiological actions of felbamate on rat striatal neurons. Br. J. Pharmacol. 116:1996;2053-2061.
31. Reeves A.L., So E.S., Sharbrough F.W., Krahn L.E. Movement disorders associated with the use of gabapentin. Epilepsia. 37:1996;988-990.
32. Sayer R.J., Brown A.M., Schwindt P.C., Crill W.E. Calcium currents in acutely isolated human neocortical neurons. J. Neurophysiol. 69:1993;1596-1606.
33. Segal, A.Z., Rordorf, G., 1996. Gabapentin as a novel treatment for postherpetic neuralgia. Neurology, 1175-1176.
34. Siesjo B.K., Bengtsson F. Calcium fluxes, calcium antagonists and calcium-related pathology in brain ischemia, hypoglycemia and spreading depression: a unyfying hypothesis. J. Cereb. Blood Flow Metab. 9:1989;127-140.
35. Siniscalchi, A., Bonci, A., Mercuri, N.B., Bernardi, G., 1996. Effect of riluzole on rat cortical neurons: an in vitro electrophysiological study. Br. J. Pharmacol. (in press).
36. Stefani A., Pisani A., Mercuri N.B., Bernardi G., Calabresi P. Activation of metabotropic glutamate receptors inhibits calcium currents and GABA-mediated synaptic potentials in striatal neurons. J. Neurosci. 14:1994;6734-6743.
37. Stefani A., Pisani A., De Murtas M., Mercuri N.B., Marciani M.G., Calabresi P. Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II Modulation of high-voltage-activated calcium currents. Epilepsia. 336:1995;997-1002.
38. Stefani A., Spadoni F., Bernardi G. Lamotrigine inhibits calcium currents in cortical neurons: functional implications. Eur. J. Pharmacol. 307:1996a;113-116.
39. Stefani A., Calabresi P., Pisani A., Mercuri N.B., Siniscalchi A., Bernardi G. Felbamate inhibits dihydropyridine-sensitive calcium channels in central neurons. J. Pharm. Exp. Ther. 277:1996b;121-129.
40. Stefani, A., Spadoni, F., Bernardi, G., 1997a. Voltage-activated calcium channels: tartget of antiepileptic drug therapy? Epilepsia 38, 959-965.
41. Stefani, A., Spadoni, F., Bernardi, G., 1997b. Differential inhibition of inward currents by lamotrigine, riluzole and phenyotin in cortical neurons: implications for neuroprotective strategies. Exp. Neurol. 747, 115-122.
42. 2+ currents in pyramidal neurons of the adult rat. Exp. Brain Res. (in press).
43. 2+ currents. J. Neurophysiol. 71:1994;1272-1280.
44. Takahashi T., Momiyama A. Different types of calcium channels mediate central synaptc transmission. Nature. 366:1993;156-158.
45. Taylor C.P., Vartanian M.G., Yuen P.W., Bigge C., Suman-Chauan N., Hill D.R. Epilepsy Res. 14:1993;11-15.
46. Tymianski M., tator CH Normal and abnormal calcium homeostasis in neurons: a basis for the pathophysiology of traumatic and ischemic central nervous system injury. Neurosurgery. 38:1996;1176-1195.
47. Wamil, A.W., McLean, M.J., Nashville, T.N., Taylor, C.P., 1991. Neurology 41 (S1), 140.
48. Wamil A.W., McLean M.J. Limitation by gabapentin of high frequency action potential firing by mouse central neurons in cell culture. Epilepsy Res. 17:1994;1-11.
49. Welty D.F., Selielke G.P., Rothstein J.D. Potential treatment of amyotrophic lateral sclerosis with gabapentin: a hypothesis. Ann. Pharmacother. 29:1995;1164-1167.
50. Williams M.E., Brust P.F., Feldman D.H. et al. Structure and fucntional expression of an ω-conotoxin-sensitive human N-type calcium channel. Science. 257:1992;389-395.
51. 2+ channel complex purified from brain. Science. 261:1993;486-489.